70
n
e
u
r
o
l
a
r
g
.
2
0
2
3;
1
5(1)
:66–70
buffering
capacity.
Neuropathol
Appl
Neurobiol.
2019;45:141–56,
http://dx.doi.org/10.1111/nan.12492
.
13.
Greenlee
JE,
Clawson
SA,
Hill
KE,
Wood
B,
Clardy
SL,
Tsunoda
I,
et
al.
Anti-Yo
antibody
uptake
and
interaction
with
its
intracellular
target
antigen
causes
Purkinje
cell
death
in
rat
cerebellar
slice
cultures:
a
possible
mechanism
for
paraneoplastic
cerebellar
degeneration
in
humans
with
gynecological
or
breast
cancers.
PLoS
One.
2015;10:e0123446,
http://dx.doi.org/10.1371/journal.pone.0123446
.
14.
Lancaster
E.
Paraneoplastic
Disorders.
Continuum
(Minneap
Minn).
2017;23(6
Neuro-oncology):1653–79,
http://dx.doi.org/10.1212/CON.
0000000000000542
.
15.
Mandel-Brehm
C,
Dubey
D,
Kryzer
TJ,
O’Donovan
BD,
Tran
B,
Vazquez
SE,
et
al.
Kelch-like
Protein
11
Antibodies
in
Seminoma-Associated
Paraneoplastic
Encephalitis.
N
Engl
J
Med.
2019;381:47–54,
http://dx.doi.org/10.1056/NEJMoa1816721
.
16.
Lukacs
S,
Szabo
N,
Woodhams
S.
Rare
association
of
anti-hu
antibody
positive
paraneoplastic
neurological
syndrome
and
transitional
cell
bladder
carcinoma.
Case
Rep
Urol.
2012;2012:724940,
http://dx.doi.org/10.1155/2012/724940
.
17.
Ketineni
S,
Kodali
S,
Gorantla
S.
A
Rare
Case
of
Sensory
Neuropathy
Associated
with
Transitional
Cell
Carcinoma
of
the
Bladder.
Case
Rep
Oncol.
2020;13:1397–401,
http://dx.doi.org/10.1159/000510742
.
18.
Cipollari
S,
Carnicelli
G,
Bicchetti
M,
Campa
R,
Pecoraro
M,
Panebianco
V.
Utilization
of
imaging
for
staging
in
bladder
cancer:
is
there
a
role
for
MRI
or
PET-computed
tomography?
Curr
Opin
Urol.
2020;30:377–86,
http://dx.doi.org/10.1097/MOU.
0000000000000743
.
19.
Stark
E,
Wurster
U,
Patzold
U,
Sailer
M,
Haas
J.
Immunological
and
clinical
response
to
immunosuppressive
treatment
in
paraneoplastic
cerebellar
degeneration.
Arch
Neurol.
1995;52:814–8,
http://dx.doi.org/10.1001/archneur.1995.00540320098016
.
20.
Vernino
S,
O’Neill
BP,
Marks
RS,
O’Fallon
JR,
Kimmel
DW.
Immunomodulatory
treatment
trial
for
paraneoplastic
neurological
disorders.
Neuro
Oncol.
2004;6:55–62,
http://dx.doi.org/10.1215/S1152851703000395
.
21.
Graus
F,
Abos
J,
Roquer
J,
Mazzara
R,
Pereira
A.
Effect
of
plasmapheresis
on
serum
and
CSF
autoantibody
levels
in
CNS
paraneoplastic
syndromes.
Neurology.
1990;40:1621–3,
http://dx.doi.org/10.1212/wnl.40.10.1621
.
22.
Shams’ili
S,
Grefkens
J,
de
Leeuw
B,
van
den
Bent
M,
Hooijkaas
H,
van
der
Holt
B,
et
al.
Paraneoplastic
cerebellar
degeneration
associated
with
antineuronal
antibodies:
analysis
of
50
patients.
Brain.
2003;126
Pt
6:1409–18,
http://dx.doi.org/10.1093/brain/awg133
.